Environmental and infectious conditions in sports

Clinics in Sports Medicine

Volumn 22, Issue 1, 2003, Pages 181-196

  Weber, Thomas S ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Sports Medicine Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NITROGEN OXIDE; OZONE;

ATHLETE; CARDIOVASCULAR FUNCTION; COLD; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; IMMUNE RESPONSE; INFECTION; MYOCARDITIS; PATHOGENESIS; PERFORMANCE; REVIEW; RISK BENEFIT ANALYSIS; UPPER RESPIRATORY TRACT INFECTION;

AIR POLLUTANTS; ALTITUDE; CARDIOVASCULAR PHYSIOLOGY; DECOMPRESSION SICKNESS; ENDOCARDITIS; HUMANS; INFECTION; MYOCARDITIS; RESPIRATORY PHYSIOLOGY; RESPIRATORY TRACT INFECTIONS; SPORTS;

EID: 0037263612     PISSN: 02785919     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5919(02)00038-8     Document Type: Review

References (46)

1. Castell L, Newsholme E. The effects of oral glutamine supplementation on athletes after prolonged, exhaustive exercise. Nutrition 1997;13:738-42.
2. Nieman D, Nehlsen-Cannarella D, Hensen D, et al. Immune response to exercise training and/or energy restriction in obese women. Med Sci Sports Exerc 1998;30:679-86.
3. Neiman D, Nehlsen-Cannarella D, Markoff P, et al. The effects of moderate exercise training on natural killer cells and acute upper respiratory tract infections. Int J Sports Med 1990;11:467-73.
4. Woods J, Davis J, Smith J. Exercise and cellular innate immune function. Med Sci Sports Exerc 1999;31:57-66.
5. Pyne D, Baker P, Fricker W, et al. Effects of an intensive 12-week training program by elite swimmers on neutrophil oxidative activity. Med Sci Sports Exerc 1995;27:536-42.
6. Nieman D. Is infection risk linked to exercise workload? Med Sci Sports Exerc 2000;32(Suppl 7):S406-11.
7. Kargotich S, Rowbottom D, Keast D, et al. Plasma glutamine changes after high intensity exercise in elite male swimmers. Med Sci Sports Exerc 1996;28:S133.
8. Keast D, Arstein D, Harper W, et al. Depression of plasma glutamine concentration after exercise stress and its possible influence on the immune system. Med J Aust 1995;162:15-8.
9. Weidner T, Anderson B, Kaminsky L, et al. Effect of a rhinovirus-caused upper respiratory illness on pulmonary function test and exercise responses. Med Sci Sports Exerc 1997;29(5):604-9.
10. Nieman D, Johanssen L, Lee J, et al. Infectious episodes in runners before and after the Los Angeles Marathon. J Sports Med Phys Fitness 1990;30:316-28.
11. Peters E, Bateman E. Ultramarathon running and upper respiratory tract infections. S Afr Med J 1983;64:582-4.
12. Peters E, Goetzsche J, et al. Vitamin C supplementation reduces the incidence of post-race symptoms of upper respiratory tract infection in ultramarathon runners. Am J Clin Nutr 1993;57:170-4.
13. Himmelstein S, Robergs R, et al. Vitamin C supplementation and upper respiratory tract infections in marathon runners. J Exercise Physiology online 1998;1(2):1-17.
14. Melham T. Atypical pneumonia in active patients. Phys Sports Med 1997;25(10):43-59.
15. Holly R, Shaffrath J, Amsterdam E. Electrocardiographic alterations associated with the hearts of athletes. Sports Med New Zeal 1998;25(3):139-48.
16. Francis G. Viral myocarditis; detection and management. Phys Sports Med 1995;23(7):63-83.
17. Karjalainen J, Heikkila J, Nieminen M, et al. Etiology of mild acute infectious myocarditis. Acta Med Scand 1983;213:65-73.
18. Maron B, Isner J, McKenna W. Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. Med Sci Sports Exerc 1994;26(Suppl 10):S261-7.
19. Vaitkus P, LeWinter M. Pericardial disease. In: Alpert J, editor. Cardiology for the primary care physician. Philadelphia: Current Med. Inc.; 1998. p. 259-66.
20. Ewy G. Infectious endocarditis. In: Alpert J, editor. Cardiology for the primary care physician. Philadelphia: Current Med. Inc.; 1998. p. 251-8.
21. Mullant C, Chua Y, Schaff H, et al. Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc 1995;70:517-25.
22. Adams W, Schelegle E. Ozone and high ventilation effects on pulmonary function and endurance performance. J Appl Physiol 1983;55:805-12.
23. Folinsbee L, Bedi J, Horvath S. Pulmonary function changes after 1-hour continuous heavy exercise in 0.21ppm ozone. J Appl Physiol 1984;57:984-8.
24. Hackney J, Linn W, Buckley R, et al. Studies in adaptation to ambient oxidant air pollution: effects of ozone exposure in Los Angeles residents vs. new arrivals. Environ Health Perspect 1976;18:141-6.
25. Farrell B, Kerr H, Kulle T. Adaptation in human subjects to the effects of inhaled ozone after repeated exposure. Am Rev Respir Dis 1979;119:725-30.
26. Speizer G, Frank R. The uptake and release of SO2 by the human nose. Arch Environ Health 1966;12:725-8.
27. Folinsbee L, Bedi J, Horvath S. Pulmonary response to threshold levels of sulfur dioxide (1.0ppm) and ozone (0.3ppm). J Appl Physiol 1985;58:1783-7.
28. Koenig J, Peirson W, Horike M, et al. Effects of SO2 plus NaCl aerosol combined with moderate exercise on pulmonary function in asthmatic adolescents. Environ Res 1981;25:340-8.
29. Bell K, Linn W, Hazucha M, et al. Respiratory effects of exposure to ozone plus sulfur dioxide in a Southem Californian and Eastern Canadians. Am Ind Hyg Assoc J 1977;38:695-705.
30. Linn W, Solomon J, Trim S, et al. Effects of exposure to 4-ppm nitrogen oxide in healthy and asthmatic volunteers. Arch Environ Health 1985;40:234-9.
31. Raven P, Drinkwater B, Ruhling R, et al. Effect of carbon monoxide and peroxyacetyl nitrate on man's maximal aerobic capacity. J Appl Physiol 1974;36:288-93.
32. Peterson J, Stewart R. Predicting the carboxyhemoglobin levels from carbon monoxide exposures. J Appl Physiol 1975;39:633-9.
33. Baumann I, Bonov P, Daniels J, et al. NSA round table: high altitude training. New Studies in Athletics 1994;9(2):23-35.
34. Baker A, Hopkins W. Altitude training for sea-level competition. Sportscience Train Tech. Internet Soc Sport Sci. http://sportsci.org/traintech/altitude/wgh.html, 1998.
35. Stray-Gundersen J, Chapman R, Levine B. "Living high-training low" altitude training improves sea level performance in male and female elite runners. J Appl Physiol 2001;91(3):1113-20.
36. Grissom C, Roach R, Samquist F, Hackett P. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 1992;116:461-5.
37. Keller H, Maggiorini M, Bartsch P, et al. Simulated descent v. dexamethasone in treatment of acute mountain sickness: a randomized trial. BMJ 1995;310:1232-5.
38. Sophocles A. High altitude pulmonary edema in Vail, Colorado, 1975-1982. West J Med 1986;144:569-73.
39. Bartsch P. High altitude pulmonary edema. Med Sci Sport Exerc 1999;31(Suppl 1):S23-7.
40. Dunnowicz A, Nooordeweir E, Nicholas R, et al. Inflammatory processes may predispose children to develop high altitude pulmonary edema. J Pediatr 1997;130:838-40.
41. Hultgren H. High altitude pulmonary edema: hemodynamic aspects. Int J Sports Med (Stuttgart) 1997;18(1):20-5.
42. Oelz O, Maggiorini M, Ritter M, et al. Prevention and treatment of high altitude pulmonary edema by a calcium channel blocker. Int J Sports Med (Stuttgart) 1992;13(Suppl 1):S65-8.
43. Cremona G, Asnaghi R, Badema P, et al. Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study. Lancet 2002;359(9303):303-9.
44. Campbell E. Decompression illness in sports divers: part I. Medscape Ortho Sports Med e Journal 1997;1(9):1-16.
45. Schwerzmann M, Seiler C. Recreational scuba diving, patent foramen ovale and their associated risks. Swiss Med Wkly 2001;131(25-26):365-74.
46. Campbell E. Decompression illness in sports divers: part II. Medscape Ortho Sports Med e Journal 1997;1(9):1-7.